Angelia A Eick-Cost
About
In The Last Decade
Angelia A Eick-Cost
26 papers receiving 249 citations
Peers
Comparison fields: 5 of 69
- Epidemiology 150
- Infectious Diseases 78
- Public Health, Environmental and Occupational Health 44
- Clinical Psychology 31
- Immunology 30
Countries citing papers authored by Angelia A Eick-Cost
This map shows the geographic impact of Angelia A Eick-Cost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelia A Eick-Cost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelia A Eick-Cost more than expected).
Fields of papers citing papers by Angelia A Eick-Cost
This network shows the impact of papers produced by Angelia A Eick-Cost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelia A Eick-Cost. The network helps show where Angelia A Eick-Cost may publish in the future.
Co-authorship network of co-authors of Angelia A Eick-Cost
This figure shows the co-authorship network connecting the top 25 collaborators of Angelia A Eick-Cost. A scholar is included among the top collaborators of Angelia A Eick-Cost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelia A Eick-Cost. Angelia A Eick-Cost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Mid-season influenza vaccine effectiveness estimates among DOD populations: a composite of data presented at VRBPAC-the Vaccines and Related Biological Products Advisory Committee-2024 meeting on influenza vaccine strain selection for the 2024-2025 influenza season. | 0 |
| 2 | 2 | |
| 3 | 9 | |
| 4 | Evaluation of ICD-10-CM-based case definitions of ambulatory encounters for COVID-19 among Department of Defense health care beneficiaries. | 2 |
| 5 | 12 | |
| 6 | Department of Defense end-of-season influenza vaccine effectiveness estimates for the 2017-2018 season. | 7 |
| 7 | Brief report: Department of Defense midseason vaccine effectiveness estimates for the 2017-2018 influenza season. | 4 |
| 8 | 9 | |
| 9 | Brief report: Mid-season influenza vaccine effectiveness estimates for the 2016-2017 influenza season. | 2 |
| 10 | 13 | |
| 11 | 5 | |
| 12 | Assessment of ICD-9-based case definitions for influenza-like illness surveillance. | 20 |
| 13 | 26 | |
| 14 | 30 | |
| 15 | 9 | |
| 16 | 8 | |
| 17 | Mid-season influenza vaccine effectiveness for the 2012-2013 influenza season. | 4 |
| 18 | 25 | |
| 19 | 11 | |
| 20 | The risk of mental health disorders among U.S. military personnel infected with human immunodeficiency virus, active component, U.S. Armed Forces, 2000-2011. | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.